GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NKY Medical Holdings Ltd (SZSE:300109) » Definitions » Deferred Tax

NKY Medical Holdings (SZSE:300109) Deferred Tax : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is NKY Medical Holdings Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

NKY Medical Holdings's change in deferred tax for the three months ended in Mar. 2024 was ¥0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.


NKY Medical Holdings Deferred Tax Historical Data

The historical data trend for NKY Medical Holdings's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKY Medical Holdings Deferred Tax Chart

NKY Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NKY Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NKY Medical Holdings Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NKY Medical Holdings Deferred Tax Related Terms

Thank you for viewing the detailed overview of NKY Medical Holdings's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.


NKY Medical Holdings (SZSE:300109) Business Description

Traded in Other Exchanges
N/A
Address
No.9 Zhongshan Road, Boai county, Jiaozuo, Henan, CHN, 454450
NKY Medical Holdings Ltd develops and manufactures polyvinylpyrrolidone (PVP) series products in China. Its products can be used in Pharmaceutical accessories, hair gel, wine products stabilizer, water treatment, glue stick, and oral care products.
Executives
Zhang Jun Zheng Directors, executives
Yang Hong Bo Director
Wang Dong Hu Director
Ren Da Long Director
Xing Xiao Liang Directors, executives
Zou Xiao Wen Executives
Wang Shi Gang Executives
Wang Xin Meng Executives
Qu Yun Xia Supervisors
Wang Jian Qiang Director
Yang Hai Jiang Director
Yan Zhong Chao Supervisors
Liu Ai Min Executives
Wu Cong Zhou Executives
Wu Wen Bin Director

NKY Medical Holdings (SZSE:300109) Headlines

No Headlines